Sleep Aids (Pharmacies) - South America

  • South America
  • Revenue in the Sleep Aids market is projected to reach US$68.09m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of -0.60%, resulting in a market volume of US$66.48m by 2028.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.16 are generated in 2024.

Key regions: South Korea, Japan, Canada, France, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in South America is experiencing significant growth and development.

Customer preferences:
Customers in South America are increasingly seeking sleep aids to address their sleep-related issues. Factors such as stress, hectic lifestyles, and the prevalence of technology are contributing to the rising demand for sleep aids. Additionally, the aging population in South America is also driving the need for sleep aids, as sleep disorders become more common with age.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in South America is the growing popularity of natural and herbal sleep aids. Customers are becoming more conscious of the potential side effects of traditional sleep aids and are seeking safer alternatives. As a result, there has been an increase in the demand for natural sleep aids, such as herbal teas, melatonin supplements, and aromatherapy products. Another trend in the market is the increasing availability and accessibility of sleep aids. Pharmacies in South America are expanding their range of sleep aid products to cater to the growing demand. Additionally, online platforms and e-commerce websites are making it easier for customers to purchase sleep aids from the comfort of their homes. This convenience factor is driving the growth of the market.

Local special circumstances:
South America is a diverse region with different cultural and economic factors influencing the Sleep Aids (Pharmacies) market. In countries like Brazil and Argentina, where the economy is relatively stable, consumers have more purchasing power and are willing to spend on sleep aids. On the other hand, in countries with weaker economies, such as Venezuela, the demand for sleep aids may be limited due to affordability issues. Furthermore, the healthcare infrastructure and regulatory environment in each country can also impact the market. Countries with well-developed healthcare systems, such as Chile and Uruguay, may have better access to sleep aids and a higher level of awareness about sleep disorders. In contrast, countries with weaker healthcare systems may face challenges in providing adequate sleep aid solutions to their population.

Underlying macroeconomic factors:
The Sleep Aids (Pharmacies) market in South America is influenced by various macroeconomic factors. Economic growth, disposable income levels, and consumer confidence play a significant role in driving the demand for sleep aids. As the economy improves and consumers have more disposable income, they are more likely to spend on sleep aids to improve their quality of life. Additionally, the prevalence of sleep disorders and the awareness about the importance of sleep are also contributing to the growth of the market. As people become more educated about the negative impacts of sleep deprivation and the benefits of a good night's sleep, they are more likely to seek sleep aids to address their sleep-related issues. In conclusion, the Sleep Aids (Pharmacies) market in South America is experiencing growth and development due to customer preferences for sleep aids, the availability of natural and herbal sleep aids, increasing accessibility, and underlying macroeconomic factors such as economic growth and awareness about sleep disorders. However, the market is also influenced by local special circumstances, including the healthcare infrastructure and regulatory environment in each country.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)